(S (NP-SBJ (NP (NNS Signals)) (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN transcription) (NN factor))))))) (VP (VBP are) (ADJP-PRD (ADJP (JJR stronger)) (PP (-NONE- *ICH*-101))) (PP (IN in) (NP (JJ neonatal) (NP (-NONE- *?*)))) (PP-101 (IN than) (NP (JJ adult) (NN T) (NNS lymphocytes)))) (. .))
(S (NP-SBJ-48 (NP (DT The) (JJ molecular) (NN background)) (PP (IN of) (NP (NP (DT the) (NNS defects)) (PP (IN in) (NP (NP (DT the) (JJ immune) (NN reactivity)) (PP (IN of) (NP (JJ human) (NNS neonates)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN elucidated) (NP (-NONE- *-48))))) (. .))
(S (SBAR (IN As) (S (NP-SBJ (DT the) (NN NF-kappa) (NN B) (NN transcription) (NN factor)) (VP (VBZ has) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (JJ several) (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses))))))))))))) (, ,) (NP-SBJ (DT the) (NNS authors)) (VP (VBP have) (VP (VBN analysed) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (JJ human) (JJ umbilical) (NN cord) (NN T) (NNS lymphocytes)))))) (. .))
(S (NP-SBJ-49 (DT The) (NN activity)) (VP (VBD was) (VP (VBN tested) (NP (-NONE- *-49)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VP (VBG quantitating) (NP (NP (DT the) (JJ nuclear) (NNS proteins)) (VP (VBG binding) (PP (TO to) (NP (NP (DT an) (NN oligonucleotide)) (VP (VBG containing) (NP (DT the) (NN consensus) (NN kappa) (NN B) (NN binding) (NN sequence)))))))) (PRN (-LRB- -LRB-) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (-RRB- -RRB-))))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS data)) (VP (VBN obtained) (NP (-NONE- *)))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (NP (NN phorbol) (NN (calcium dibutyrate)) (NN ionophore) (NN A23187)) (PRN (-LRB- -LRB-) (NP (NN (iono PDBu))) (-RRB- -RRB-))) (NN combination)) (VP (VBD induced) (NP (NP (NP (DT a) (ADJP (RB clearly) (JJR higher)) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (JJ neonatal) (NP (-NONE- *?*))))) (PP (IN than) (NP (JJ adult) (NN T) (NNS cells)))))))) (. .))
(S (NP-SBJ-50 (DT This) (JJR higher) (NN NF-kappa) (NN B) (NN activity)) (VP (VBD was) (VP (JJ restricted) (NP (-NONE- *-50)) (PP (TO to) (NP (DT the) (JJ CD4+) (NN T-cell) (NN subset))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (JJ nuclear) (NNS extracts)) (PP (IN with) (NP (NP (NNS antibodies)) (VP (VBN directed) (NP (-NONE- *)) (PP (IN against) (NP (NP (DT the) (JJ major) (NNS components) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (DT the) (NP-COOD (NP (NN p50)) (CC and) (NP (NN RelA) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-)))) (NNS proteins) (, ,))))))))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN composition)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBD was) (ADJP-PRD (JJ similar)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ neonatal)) (CC and) (ADJP (JJ adult))) (NNS cells))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-51 (JJ neonatal) (NN T) (NNS cells)) (VP-COOD (VP (VBP are) (VP (VBN exposed) (NP (-NONE- *-51)) (PP (TO to) (NP (ADJP (JJ oxidative) (JJ stress-inducing)) (NNS signals))) (PP-TMP (IN during) (NP (NN delivery))))) (CC (or and)) (VP (VBP are) (ADVP (RB inherently)) (ADJP-PRD (ADJP (RBR more) (JJ sensitive) (PP (TO to) (NP (NN NF-kappa) (NN B) (NN activating) (NNS signals)))) (PP (IN than) (NP (JJ adult) (NN T) (NNS cells))))))))) (. .))
